[1] Sirajuddin A, Raparia K, Lewis VA, et al.  Primary pulmonary lymphoid lesions: radiologic and pathologic findings[J]. Radiographics, 2016, 36(1): 53-70.   doi: 10.1148/rg.2016140339
[2] Bray F, Ferlay J, Soerjomataram I, et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.   doi: 10.3322/caac.21492
[3] Ettinger DS, Aisner DL, Wood DE, et al.  NCCN guidelines insights: non-small cell lung cancer, version 5.2018[J]. J Natl Compr Canc Netw, 2018, 16(7): 807-821.   doi: 10.6004/jnccn.2018.0062
[4]

Deng W, Wan Y, Yu JQ. Pulmonary MALT lymphoma has variable features on CT[J/OL]. Sci Rep, 2019, 9(1): 8657[2021-02-16]. https://www.nature.com/articles/s41598-019-45144-9. DOI: 10.1038/s41598-019-45144-9.
[5] Ferraro P, Trastek VF, Adlakha H, et al.  Primary non-Hodgkin's lymphoma of the lung[J]. Ann Thorac Surg, 2000, 69(4): 993-997.   doi: 10.1016/s0003-4975(99)01535-0
[6] Kawashima T, Nishimura H, Akiyama H, et al.  Primary pulmonary mucosa-associated lymphoid tissue lymphoma combined with idiopathic thrombocytopenic purpura and amyloidoma in the lung[J]. J Nippon Med Sch, 2005, 72(6): 370-374.   doi: 10.1272/jnms.72.370
[7] 彭思达, 谭获, 黄振倩, 等.  肺黏膜相关淋巴组织样淋巴瘤7例并临床诊断与分析[J]. 中国肿瘤临床, 2014, 41(14): 922-924.   doi: 10.3969/j.issn.1000-8179.20131268
Peng SD, Tan H, Huang ZQ, et al.  Clinical diagnosis and analysis of primary pulmonary mucosa-associated lymphoid tissue lymphoma: a report of seven cases[J]. Chin J Clin Oncol, 2014, 41(14): 922-924.   doi: 10.3969/j.issn.1000-8179.20131268
[8] 陈勃江, 高俊, 唐源, 等.  肺粘膜相关淋巴组织边缘区B细胞淋巴瘤的临床病理分析[J]. 中国肺癌杂志, 2011, 14(5): 446-451.   doi: 10.3779/j.issn.1009-3419.2011.05.12
Chen BJ, Gao J, Tang Y, et al.  Clinicopathological analysis of pulmonary marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue[J]. Chin J Lung Cancer, 2011, 14(5): 446-451.   doi: 10.3779/j.issn.1009-3419.2011.05.12
[9] Jung JI, Kim H, Park SH, et al.  CT differentiation of pneumonic-type bronchioloalveolar cell carcinoma and infectious pneumonia[J]. Br J Radiol, 2001, 74(882): 490-494.   doi: 10.1259/bjr.74.882.740490
[10] Akata S, Fukushima A, Kakizaki D, et al.  CT scanning of bronchioloalveolar carcinoma: specific appearances[J]. Lung Cancer, 1995, 12(3): 221-230.   doi: 10.1016/0169-5002(95)00445-7
[11] Albano D, Borghesi A, Bosio G, et al.  Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients[J]. Br J Radiol, 2017, 90(1079): 20170311-.   doi: 10.1259/bjr.20170311
[12] Albano D, Durmo R, Treglia G, et al.  18F-FDG PET/CT or PET role in MALT lymphoma: an open issue not yet solved-a critical review[J]. Clin Lymphoma Myeloma Leuk, 2020, 20(3): 137-146.   doi: 10.1016/j.clml.2019.10.006
[13]

Cohen D, Perry C, Hazut-Krauthammer S, et al. Is there a role for [18F]FDG PET-CT in staging MALT lymphoma?[J/OL]. Cancers, 2022, 14(3): 750[2022-02-16]. https://www.mdpi.com/2072-6694/14/3/750. DOI: 10.3390/cancers14030750.
[14] 雷强, 李新春, 万齐, 等.  肺黏膜相关淋巴组织淋巴瘤的CT、PET/CT表现及预后随访[J]. 中国临床医学影像杂志, 2018, 29(9): 620-623, 639.   doi: 10.12117/jccmi.2018.09.004
Lei Q, Li XC, Wan Q, et al.  Pulmonary mucosa-associated lymphoid tissue lymphoma: CT and PET/CT imaging findings and follow-up[J]. J China Clin Med Imag, 2018, 29(9): 620-623, 639.   doi: 10.12117/jccmi.2018.09.004
[15]

Husnain M, Kuker R, Reis IM, et al. Clinical and radiological characteristics of patients with pulmonary marginal zone lymphoma: a single center analysis[J/OL]. Cancer Med, 2020, 9(14): 5051−5064[2022-02-16]. https://onlinelibrary.wiley.com/doi/10.1002/cam4.3096. DOI: 10.1002/cam4.3096.
[16] Hoffmann M, Wöhrer S, Becherer A, et al.  18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference[J]. Ann Oncol, 2006, 17(12): 1761-1765.   doi: 10.1093/annonc/mdl295
[17] Albano D, Bosio G, Giubbini R, et al.  18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation[J]. Leuk Lymphoma, 2017, 58(10): 2328-2334.   doi: 10.1080/10428194.2017.1298754
[18] Albano D, Bosio G, Camoni L, et al.  Prognostic role of baseline 18F-FDG PET/CT parameters in MALT lymphoma[J]. Hematol Oncol, 2019, 37(1): 39-46.   doi: 10.1002/hon.2563
[19] Zhao J, Wang HQ.  Correlation between 18F-FDG PET/CT semiquantitative parameters and Ki-67 expression in pulmonary mucosa-associated lymphoid tissue lymphoma[J]. J Med Imaging Radiat Oncol, 2021, 65(2): 188-194.   doi: 10.1111/1754-9485.13146
[20] Yang XB, Min XX, He WM.  Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: a case report[J]. Medicine, 2018, 97(21): e10845-.   doi: 10.1097/MD.0000000000010845
[21] Wainer Z, Daniels MG, Callahan J, et al.  Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer[J]. J Nucl Med, 2012, 53(11): 1676-1685.   doi: 10.2967/jnumed.112.105197
[22] Mercieca S, Belderbos J, Van Loon J, et al.  Comparison of SUVmax and SUVpeak based segmentation to determine primary lung tumour volume on FDG PET-CT correlated with pathology data[J]. Radiother Oncol, 2018, 129(2): 227-233.   doi: 10.1016/j.radonc.2018.06.028